Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-24 @ 5:33 PM
NCT ID:
NCT00976768
Eligibility Criteria:
Inclusion Criteria:
* Pathologically proven non-resectable adenocarcinoma of stomach
* Measurable disease based on Response Criteria in Solid Tumors (RECIST)
* Prior chemotherapy with taxane, fluoropyrimidine, and cisplatinum in combination or sequentially, there is no time limit for the last chemotherapy
* Age 18 to 70 years old
* Estimated life expectancy of more than 3 months
* Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
* Adequate bone marrow function (white blood cell counts \>4,000/µL, absolute neutrophil count \[ANC\]\>1,500/µL, hemoglobin \>9.0 g/dL, and platelets\>100,000/µL),
* Adequate kidney function (creatinine\<1.5 mg/dL)
* Adequate liver function (bilirubin\<1.5 mg/dL , transaminases levels\<3 times the upper normal limit \[5 times for patients with liver metastasis\], and serum albumin of \>2.5 mg/dL)
Exclusion Criteria:
* Other tumor type than adenocarcinoma
* Presence or history of central nervous system metastasis
* Obvious or impending bowel obstruction (including obvious peritoneal carcinomatosis)
* Evidence of active gastrointestinal bleeding
* Other serious illness or medical conditions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00976768
Study Brief:
Protocol Section:
NCT00976768